John Stansel
Stock Analyst at JP Morgan
(1.40)
# 3,534
Out of 5,172 analysts
14
Total ratings
57.14%
Success rate
-2.06%
Average return
Main Sectors:
Stocks Rated by John Stansel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CNC Centene | Maintains: Neutral | $45 → $41 | $34.40 | +19.19% | 5 | Mar 19, 2026 | |
| HSIC Henry Schein | Maintains: Overweight | $78 → $92 | $72.29 | +27.27% | 2 | Feb 25, 2026 | |
| ALHC Alignment Healthcare | Maintains: Overweight | $23 → $26 | $17.34 | +49.94% | 2 | Feb 5, 2026 | |
| MOH Molina Healthcare | Maintains: Neutral | $272 → $184 | $139.41 | +31.98% | 2 | Jul 29, 2025 | |
| DGX Quest Diagnostics | Maintains: Neutral | $148 → $149 | $195.26 | -23.69% | 1 | Nov 17, 2023 | |
| LH Labcorp Holdings | Maintains: Overweight | $259 → $261 | $263.00 | -0.76% | 1 | Nov 17, 2023 | |
| ONON On Holding AG | Initiates: Buy | $31 | $37.66 | -17.68% | 1 | Apr 19, 2022 |
Centene
Mar 19, 2026
Maintains: Neutral
Price Target: $45 → $41
Current: $34.40
Upside: +19.19%
Henry Schein
Feb 25, 2026
Maintains: Overweight
Price Target: $78 → $92
Current: $72.29
Upside: +27.27%
Alignment Healthcare
Feb 5, 2026
Maintains: Overweight
Price Target: $23 → $26
Current: $17.34
Upside: +49.94%
Molina Healthcare
Jul 29, 2025
Maintains: Neutral
Price Target: $272 → $184
Current: $139.41
Upside: +31.98%
Quest Diagnostics
Nov 17, 2023
Maintains: Neutral
Price Target: $148 → $149
Current: $195.26
Upside: -23.69%
Labcorp Holdings
Nov 17, 2023
Maintains: Overweight
Price Target: $259 → $261
Current: $263.00
Upside: -0.76%
On Holding AG
Apr 19, 2022
Initiates: Buy
Price Target: $31
Current: $37.66
Upside: -17.68%